Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000531919 | SCV000650559 | uncertain significance | Aortic aneurysm, familial thoracic 7 | 2023-05-01 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MYLK protein function. ClinVar contains an entry for this variant (Variation ID: 471733). This variant has not been reported in the literature in individuals affected with MYLK-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.0009%). This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 1707 of the MYLK protein (p.Arg1707His). |
Gene |
RCV001755871 | SCV002006550 | uncertain significance | not provided | 2020-08-14 | criteria provided, single submitter | clinical testing | Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
CHEO Genetics Diagnostic Laboratory, |
RCV001798894 | SCV002043676 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2020-06-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001798894 | SCV002642234 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2020-08-17 | criteria provided, single submitter | clinical testing | The p.R1707H variant (also known as c.5120G>A), located in coding exon 28 of the MYLK gene, results from a G to A substitution at nucleotide position 5120. The arginine at codon 1707 is replaced by histidine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |